>> only nbix on my screen <<
price:book of about 5, you must not be excited about either alzheimer's or 6827??......
1. Predictive Medicine, profitable, $70M annualized sales 2. R-flurbiprofen, phase III human trial, Alzheimer's 3. MPC-6827, phase I human trial, solid cancers 4. MPC-2130, phase I human trial, solid and blood cancers 5. MPI-49839, advanced preclinical formulation, HIV 6. R-flurbiprofen, phase II human trial, prostate Ca 7. NK-1R/substance P antagonist for CINV, advanced preclinical 8. 100 person cancer-dedicated sales force 9. deep pipeline/DEP-1 with Abbott 10. Prolexys pipeline and cash, 49% 11. Rice genome, 50% 12. NIAID "host-pathogen interaction" contract 13. $124M cash, $154M book, clean balance sheet (12/31) |